A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer

~18 mi. (Alessandria, Italy, +383 more cities)

Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria

ER Negative, +2 more biomarkers

Breast Carcinoma

atezolizumab, +4 more drugs

chemotherapy, +1 more type

Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH

~18 mi. (Alessandria, Italy, +122 more cities)

A.O. Nazionale SS Antonio e Biagio e Cesare Arrigo

Prostate Adenocarcinoma

radium Ra 223 dichloride

radiation therapy

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

~24 mi. (Casale Monferrato, Italy, +97 more cities)

ASL Regionale Piemonte - Ospedale Santo Spirito Casale Monferrato (Ospedale di Casale Monferrato)

Microsatellite Stable (MSS)

Colorectal Adenocarcinoma

bevacizumab, +2 more drugs

chemotherapy, +1 more type

A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

~27 mi. (Pavia, Italy, +206 more cities)

Fondazione IRCCS Policlinico San Matteo

PD-L1 Expression (CPS >= 1), +5 more biomarkers

Non-Small Cell Lung Carcinoma

atezolizumab, +1 more drug

immunotherapy

Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

~27 mi. (Pavia, Italy, +141 more cities)

GSK Investigational Site

Multiple Myeloma

belantamab mafodotin

chemotherapy, +1 more type

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

~27 mi. (Pavia, Italy, +64 more cities)

Fondazione S. Maugeri IRCCS

ER Positive, +1 more biomarker

Breast Carcinoma

anastrozole, +2 more drugs

hormone therapy

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

~27 mi. (Pavia, Italy, +74 more cities)

GSK Investigational Site

Multiple Myeloma

belantamab mafodotin, +3 more drugs

chemotherapy, +2 more types

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

~36 mi. (Trino, Italy, +103 more cities)

Dipartimento di Scienze Pediatriche Adolescenza; Osp. Infantile Regina Margherita

AKT1 Mutation, +39 more biomarkers

Malignant Solid Tumor

ado-trastuzumab emtansine, +8 more drugs

immunotherapy, +1 more type

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

~36 mi. (Trino, Italy, +81 more cities)

Azienda Ospedaliera Ordine Mauriziano di Torino

Hepatocellular Carcinoma

atezolizumab, +2 more drugs

immunotherapy, +1 more type

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

~36 mi. (Trino, Italy, +62 more cities)

Ospedale Infantile Regina Margherita - INCIPIT - PIN

ABL1 Fusion, +31 more biomarkers

Acute Lymphoblastic Leukemia, +1 more condition

chemotherapy, +1 more drug

chemotherapy, +1 more type

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

~36 mi. (Trino, Italy, +37 more cities)

A. O. Città della Salute e della Scienza di Torino; SC Oncoematologia e Centro Trapianti AOOIRM

NTRK1 Fusion, +3 more biomarkers

Malignant Solid Tumor

entrectinib

targeted therapy

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

~39 mi. (Rozzano, Italy, +89 more cities)

Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1114)

ER Positive, +2 more biomarkers

Breast Carcinoma

capecitabine, +4 more drugs

chemotherapy, +1 more type